通过改善IGF2BP1依赖的CCL5上调,CircMAPK1促进了LUAD中的CD8+T细胞透
Feng Zhao1, Guorong Zhu2, Jing He1
1Department of Thoracic Surgery, The Sixth Clinical Medical College and Affiliated Hospital of Yangzhou University, The Teaching Hospital of Kangda College of Nanjing Medical University, Taixing People's Hospital, Taizhou, Jiangsu, China.
circMAPK1,一种新型的circRNA,增强了肺腺癌 (LUAD) 中的CD8+T细胞透. 过度表达circMAPK1可以提高抗瘤免疫力,并可能增强LUAD患者的免疫治疗反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺腺癌 (LUAD) 的预后不好,免疫检查点阻塞 (ICB) 提供了更好的生存率.
- CD8+ T细胞透对于LUAD预后和ICB疗效至关重要.
- 由瘤细胞和微环境细胞分泌的化学基因调节CD8+ T细胞的招募.
研究的目的:
- 研究circMAPK1在LUAD进展和免疫细胞透中的作用.
- 探索circMAPK1作为增强ICB反应的治疗点的潜力.
主要方法:
- 在LUAD.中研究circMAPK1的表达.
- 在LUAD模型中过度表达的circMAPK1 (体外和体内).
- 分析了circMAPK1涉及IGF2BP1和CCL5mRNA稳定的机制.
主要成果:
- 在LUAD中发现circMAPK1的下调.
- 过度表达circMAPK1抑制了LUAD生长,并促进了CD8+ T细胞的透.
- circMAPK1与IGF2BP1结合,使CCL5mRNA稳定,从而招募CD8+T细胞.
结论:
- circMAPK1作为一个与微环境相关的circRNA,在LUAD中招募CD8+T细胞.
- circMAPK1是一种潜在的治疗剂,可以增强LUAD中的ICB疗效.
更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
相关概念视频
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
